Description
Thermo Fisher Scientific: Emerging Market Potential & Resilience As A Key To Its Growth Strategy!
Thermo Fisher Scientific’s second-quarter 2025 earnings showcased a company navigating a challenging macroeconomic environment positively and prudently. The company reported revenue growth of 3% to $10.85 billion and a 1% increase in adjusted operating income to $2.38 billion. Its adjusted earnings per share (EPS) was $5.36, signaling an ability to surpass internal guidance despite headwinds, primarily from tariffs affecting operations in China and broader policy uncertainties.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
